NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDS: ANTIVIRALS, HIV

抗肿瘤化合物的新合成方法：抗病毒药物、HIV

• 批准号: 7601801
• 负责人: BARRY M TROST
• 金额: $ 19.36万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-30 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7601801
• 关键词: Alkaloids; Antiviral Agents; Class; Computer Retrieval of Information on Scientific Projects Database; Development; Funding; Grant; Institution; Research; Research Personnel; Resources; Source; Terpenes; United States National Institutes of Health; analog; novel; programs

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The program involves the development of synthetic strategies to compounds of known antitumor activity to generate structurally related but inaccessible analogues. Compounds of many different classes, including alkaloids, terpenoids, and polyacetates are being examined.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此，可以在其他清晰的条目中表示。列出的机构是 对于中心，这不一定是调查员的机构。 该计划涉及开发合成策略，以使已知抗肿瘤活性的化合物产生结构相关但无法接近的类似物。 正在研究许多不同类别的化合物，包括生物碱，萜类化合物和多乙二酸。